Alterity Therapeutics Limited Stock Buy Hold or Sell Recommendation
| PRNAF Stock | USD 0 0.00 0.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Alterity Therapeutics Limited is 'Strong Sell'. Macroaxis provides Alterity Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding PRNAF positions.
Check out Alterity Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Alterity Pink Sheet please use our How to Invest in Alterity Therapeutics guide. Note, we conduct extensive research on individual companies such as Alterity and provide practical buy, sell, or hold advice based on investors' constraints. Alterity Therapeutics Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Alterity |
Execute Alterity Therapeutics Buy or Sell Advice
The Alterity recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Alterity Therapeutics Limited. Macroaxis does not own or have any residual interests in Alterity Therapeutics Limited or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Alterity Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Alterity Therapeutics Trading Alerts and Improvement Suggestions
| Alterity Therapeutics generated a negative expected return over the last 90 days | |
| Alterity Therapeutics has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (12.85 M) with profit before overhead, payroll, taxes, and interest of 4.76 M. | |
| Alterity Therapeutics Limited has accumulated about 34.81 M in cash with (12.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 15.0% of the company outstanding shares are owned by corporate insiders |
Alterity Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Alterity Therapeutics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Alterity Therapeutics' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Alterity pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Alterity Therapeutics Volatility Alert
At this time Alterity Therapeutics Limited exhibits very low volatility. Alterity Therapeutics Limited is a penny stock. Even though Alterity Therapeutics may be a good instrument to invest, many penny pink sheets are speculative instruments that are subject to artificial stock promotions. Please make sure you fully understand upside and downside scenarios of investing in Alterity Therapeutics Limited or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings,sudden promotions and many other similar artificial hype indicators. We also encourage traders to check work history of company executives before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Alterity instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Alterity Therapeutics Fundamentals Vs Peers
Comparing Alterity Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Alterity Therapeutics' direct or indirect competition across all of the common fundamentals between Alterity Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Alterity Therapeutics or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Alterity Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Alterity Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Alterity Therapeutics to competition |
| Fundamentals | Alterity Therapeutics | Peer Average |
| Return On Equity | -0.39 | -0.31 |
| Return On Asset | -0.26 | -0.14 |
| Profit Margin | (2.51) % | (1.27) % |
| Operating Margin | (3.03) % | (5.51) % |
| Current Valuation | (7.2 M) | 16.62 B |
| Shares Outstanding | 2.41 B | 571.82 M |
| Shares Owned By Insiders | 15.14 % | 10.09 % |
| Shares Owned By Institutions | 0.33 % | 39.21 % |
| Price To Earning | 0.88 X | 28.72 X |
| Price To Book | 0.67 X | 9.51 X |
| Price To Sales | 3.12 X | 11.42 X |
| Gross Profit | 4.76 M | 27.38 B |
| EBITDA | (15.08 M) | 3.9 B |
| Net Income | (12.85 M) | 570.98 M |
| Cash And Equivalents | 34.81 M | 2.7 B |
| Cash Per Share | 0.01 X | 5.01 X |
| Total Debt | 117.49 K | 5.32 B |
| Debt To Equity | 0 % | 48.70 % |
| Current Ratio | 7.07 X | 2.16 X |
| Book Value Per Share | 0.01 X | 1.93 K |
| Cash Flow From Operations | (12.34 M) | 971.22 M |
| Earnings Per Share | (0) X | 3.12 X |
| Number Of Employees | 12 | 18.84 K |
| Beta | 0.87 | -0.15 |
| Market Capitalization | 18.77 M | 19.03 B |
| Total Asset | 41.36 M | 29.47 B |
| Retained Earnings | (125 M) | 9.33 B |
| Working Capital | 32 M | 1.48 B |
| Current Asset | 34 M | 9.34 B |
| Current Liabilities | 2 M | 7.9 B |
| Z Score | 91.2 | 8.72 |
| Net Asset | 41.36 M |
Alterity Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Alterity . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.0036 | |||
| Day Typical Price | 0.0036 |
About Alterity Therapeutics Buy or Sell Advice
When is the right time to buy or sell Alterity Therapeutics Limited? Buying financial instruments such as Alterity Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Alterity Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Pharmaceutical Products Thematic Idea Now
Pharmaceutical Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Pharmaceutical Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Pharmaceutical Products Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Alterity Pink Sheet
Alterity Therapeutics financial ratios help investors to determine whether Alterity Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alterity with respect to the benefits of owning Alterity Therapeutics security.